Hospital Universitario Virgen De La Victoria | Oncologia

Málaga 29010

1 studies enrolling now · 3 studies all time

What they study most

Advanced Non-small Cell Lung Cancer, Cancer, EGFR Mutation, HER2 Mutation, MTAP-deleted Solid Tumors

Studies at this site

• First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2) — Recruiting now
• A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors — Recruiting now
• Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer — Running, not enrolling